Felipo-Benavent Mar, Martínez-Romero Alicia, Valls Mónica, Rojo-Solís Carlos, Álvaro Teresa, García-Párraga Daniel, Rubio-Guerri Consuelo, O'Connor José-Enrique
Laboratory of Cytomics, Joint Research Unit CIPF-UVEG, Department of Biochemistry and Molecular Biology, University of Valencia, Valencia, Spain.
Department of Biomedical Sciences, Faculty of Health Sciences, Universidad CEU Cardenal Herrera, CEU Universities, Valencia, Spain.
Front Vet Sci. 2024 May 2;11:1389977. doi: 10.3389/fvets.2024.1389977. eCollection 2024.
The study of the immune function in marine mammals is essential to understand their physiology and can help to improve their welfare in the aquariums. Dedicating efforts to studying marine mammal physiology, pathophysiology, and implementing new diagnostic and therapeutic tools promote progress towards preventive medicine in aquariums by facilitating early detection and treatment of diseases. However, biological and clinical research on marine mammals is currently very limited due to difficult access to these species and their biological samples. With this objective, our group has adapted to marine mammals a commercially available assay routinely used to evaluate the phagocytic capacity of monocytes and granulocytes in human whole blood samples. We adapted IngoflowEx kit to bottlenose dolphins (), beluga whales (), walruses (), Patagonian sea lions (), and harbor (). In this paper, we report the modifications carried out on the original protocol for their correct functioning in marine mammals. We obtained physiological values of phagocytic capacity in each species after repeated sampling for 4 years in various individuals of each species. Specific results revealed that the % phagocytic cells that ingested E.coli in bottlenose dolphins were 59.6 ± 1.27, in walruses 62.6 ± 2.17, in sea lions 57.5 ± 4.3, and in beluga whales 61.7 ± 1.4. In the case of the % phagocytic cells producing respiratory burst in bottlenose dolphins were 34.2 ± 3.6, in walruses 36.3 ± 4.3, in sea lions 40.8 ± 10.2, and in beluga whales 26.3 ± 3.7. These preliminary results can be used as a reference to detect alterations in phagocytic capacity either by immunosuppression or by exacerbation of the response in infectious inflammatory processes. Clinical applicability of the assay was verified in two clinical cases in which Ingoflow was useful to detect immune alterations in two diseased individuals, before and after the onset of clinical signs.
研究海洋哺乳动物的免疫功能对于了解它们的生理机能至关重要,并且有助于改善它们在水族馆中的福利状况。致力于研究海洋哺乳动物的生理学、病理生理学,并应用新的诊断和治疗工具,通过促进疾病的早期发现和治疗,推动水族馆预防医学的发展。然而,由于难以获取这些物种及其生物样本,目前关于海洋哺乳动物的生物学和临床研究非常有限。出于这一目的,我们团队对一种常用于评估人类全血样本中单核细胞和粒细胞吞噬能力的市售检测方法进行了调整,使其适用于海洋哺乳动物。我们将IngoflowEx试剂盒应用于宽吻海豚、白鲸、海象、巴塔哥尼亚海狮和港湾海豹。在本文中,我们报告了为使该检测方法在海洋哺乳动物中正常运行而对原始方案所做的修改。在对每个物种的多个个体进行了4年的重复采样后,我们获得了每个物种吞噬能力的生理值。具体结果显示,宽吻海豚中吞噬大肠杆菌的吞噬细胞百分比为59.6±1.27,海象为62.6±2.17,海狮为57.5±4.3,白鲸为61.7±1.4。在宽吻海豚中产生呼吸爆发的吞噬细胞百分比为34.2±3.6,海象为36.3±4.3,海狮为40.8±10.2,白鲸为26.3±3.7。这些初步结果可作为参考,用于检测在免疫抑制或感染性炎症过程中反应加剧时吞噬能力的改变。该检测方法的临床适用性在两个临床病例中得到了验证,在这两个病例中,Ingoflow在检测两个患病个体临床症状出现前后的免疫改变方面很有用。